Silo Pharma Files S-1/A Amendment

Ticker: SILO · Form: S-1/A · Filed: Apr 29, 2025 · CIK: 1514183

Silo Pharma, Inc. S-1/A Filing Summary
FieldDetail
CompanySilo Pharma, Inc. (SILO)
Form TypeS-1/A
Filed DateApr 29, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: s-1/a, amendment, pharmaceuticals, ipo

Related Tickers: SILO

TL;DR

Silo Pharma (formerly Uppercut Brands) filed an S-1/A, signaling progress on its public offering. $SILO

AI Summary

Silo Pharma, Inc. filed an S-1/A amendment on April 29, 2025, for its registration statement (No. 333-286777). The company, formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located at 677 N. Washington Blvd, Sarasota, Florida.

Why It Matters

This filing indicates Silo Pharma is moving forward with its public offering plans, which could lead to increased capital for operations and expansion in the pharmaceutical sector.

Risk Assessment

Risk Level: medium — S-1/A filings often precede public offerings, which carry inherent market and execution risks for emerging companies.

Key Numbers

  • 333-286777 — SEC Registration Number (Identifies the specific registration statement being amended.)
  • 20250429 — Filing Date (The date this amendment was officially submitted to the SEC.)

Key Players & Entities

  • Silo Pharma, Inc. (company) — Registrant
  • 0001213900-25-036374 (filing_id) — Accession Number
  • 20250429 (date) — Filing Date
  • 333-286777 (registration_number) — SEC File Number
  • Eric Weisblum (person) — Chief Executive Officer
  • Uppercut Brands, Inc. (company) — Former Company Name
  • Point Capital, Inc. (company) — Former Company Name
  • Gold Swap Inc (company) — Former Company Name
  • Nevada (jurisdiction) — State of Incorporation
  • 2834 (sic_code) — Standard Industrial Classification Code

FAQ

What is the primary purpose of this S-1/A filing?

This S-1/A filing is an amendment to Silo Pharma, Inc.'s registration statement, indicating updates or revisions to their initial public offering plans.

What were Silo Pharma's previous names?

Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc.

In which state is Silo Pharma, Inc. incorporated?

Silo Pharma, Inc. is incorporated in Nevada.

Who is the Chief Executive Officer of Silo Pharma, Inc.?

Eric Weisblum is the Chief Executive Officer of Silo Pharma, Inc.

What is the SIC code for Silo Pharma, Inc.?

The Standard Industrial Classification (SIC) code for Silo Pharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form S-1/A (Form S-1/A) was filed with the SEC on April 29, 2025 by Eric Weisblum regarding Silo Pharma, Inc. (SILO).

View full filing on EDGAR

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.